HemaSphere (Jun 2022)

P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY.

  • G. Cartron, MD, PhD,
  • E. Bachy, MD, PhD,
  • H. Tilly, MD,
  • N. Daguindau, MD,
  • G.-M. Pica, MD,
  • F. Bijou, MD,
  • C. Mounier, MD,
  • A. M. Clavert, MD,
  • G. L. Damaj, MD, PhD,
  • B. Slama, MD,
  • O. Casasnovas, MD,
  • R. Houot, MD, PhD,
  • K. Bouabdallah, MD,
  • D. Sibon, MD, PhD,
  • O. Fitoussi, MD,
  • N. Morineau, MD,
  • C. Herbaux, MD, PhD,
  • T. Gastinne, MD,
  • L.-M. Fornecker, MD,
  • C. Haioun, MD, PhD,
  • V. Launay, MD,
  • C. Araujo, MD,
  • O. Benbrahim, MD,
  • L. Sanhes, MD,
  • R. Gressin, MD,
  • H. Gonzalez, MD,
  • F. Morschhauser, MD, PhD,
  • L. Xerri, MD, PhD,
  • K. Tarte, PhD,
  • D. Pranger, MD

DOI
https://doi.org/10.1097/01.HS9.0000847400.79465.e8
Journal volume & issue
Vol. 6
pp. 1023 – 1024

Abstract

Read online

No abstracts available.